.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A Los Angeles jury recently sided with Johnson & Johnson in a significant lawsuit involving cosmetic talc. The families of three deceased women claimed that the company's baby powder caused their ovarian cancer. However, the jury found that the manufacturer was not negligent. This high-profile verdict highlights the ongoing scientific debate surrounding talc ovarian cancer risk. Consequently, healthcare providers must understand the latest research to guide patient counseling.
Researchers have studied the potential association between perineal talc use and ovarian malignancies for decades. Specifically, some experts suggest that talc particles can migrate through the reproductive tract. This migration could theoretically trigger chronic inflammatory pathways in the ovaries. In contrast, large-scale clinical evidence remains highly controversial. Retrospective case-control studies frequently report a modest risk increase. Conversely, prospective cohort studies generally show no strong or statistically significant association. Therefore, major oncological and gynecological societies do not recommend routine screenings based solely on talcum powder exposure.
When patients ask about cosmetic powders, clinicians should provide balanced and evidence-based information. First, doctors can explain that many manufacturers have transitioned to safer cornstarch-based alternatives. For instance, Johnson & Johnson stopped selling talc-based baby powder in the United States in 2020. Additionally, practitioners should emphasize established ovarian cancer risk factors. Furthermore, these factors include older age, family history, and genetic mutations. Ultimately, open communication helps patients make informed personal care choices.
Q1: What did the Los Angeles jury decide regarding J&J's talc products?
The jury ruled that Johnson & Johnson was not negligent when selling its cosmetic talc products, rejecting claims that they caused ovarian cancer in three women.
Q2: Is there a proven clinical link between talcum powder and ovarian cancer?
Epidemiological studies show mixed results. Retrospective studies often suggest a modest risk increase, whereas large prospective cohort studies generally find no statistically significant overall association.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Los Angeles jury sided with J&J in a major talc lawsuit. Learn about the epidemiological evidence on cosmetic talcum powder and ovarian cancer risks....
4 months ago
Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today
Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today
Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today
Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today
A Brazilian birth cohort reveals significant sex-specific associations between preterm birth and adolescent adiposity, underscoring the urgent need for targeted long-term cardiometabolic surveillance and tailored clinical monitoring.
Today
